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Class I antigens consist of a 45,000-dalton glycoprotein heavy chain associated 
noncovalently with beta-2 microglobulin and found on the surface of all cells. In 
the  mouse,  four such  Class  I  antigens  have been  defined to date,  one (H-2K) 
encoded in the K  region, and  three (D,  L,  R) encoded in  the D  region of the 
major histocompatibility complex (MHC) 1 (1, 2).  However, it is now clear from 
DNA hybridization studies with Class I  DNA probes that there are many more 
copies of DNA sequences homologous to Class I-like genes in the mouse genome 
than  have been demonstrated to be expressed in any haplotype (3,  4).  Two of 
these  Class  I-like  2 genes  have  been  identified  by  their  determination  of TL 
antigens (5), antigens that are expressed only on thymus and leukemia cells, and 
that are encoded by genes  located ~1.5  centimorgans  to the right of the  H-2 
complex along chromosome 17 (6, 7). Another of these genes has been reported 
to encode for the Qa 2 antigen (5), which is expressed only on certain subpopu- 
lations  of  peripheral  lymphoid  cells  (8)  and  which  was  recently  defined  by 
monoclonal antibodies (9-11).  However, there remain numerous other Class I- 
like sequences, the products of which are either not expressed or have not yet 
been detected. 
In  addition  to  DNA  sequence  homology  between  the  genes  encoding  H-2 
products  and  those  encoding  TL  and  Qa  antigens,  unique  similarities  exist 
between their gene products.  Analogous to H-2 antigens,  TL and Qa antigens 
are glycoproteins of ~40-45,000  daltons associated  with beta-2  microglobulin 
(12). In addition, Qa antigens, like H-2K and H-2D function as direct targets for 
cytotoxic T  cells  (13-15).  However,  in  contrast  to  the  H-2  response,  in  vivo 
priming is  required to elicit anti-Qa  responses (13-15).  There are at least two 
other major differences between  H-2 antigens  and  Qa/TL  antigens.  As  noted 
Abbreviations used in this paper: CR, cross-reactive; FITC,  fluorescein isothiocyanate-conju- 
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nal antibody; MHC, major histocompatibility  complex; TRA, Texas-red conjugated avidin. 
2  The products of H-2D-linked loci, Qa and Tla, are sometimes considered Class I antigens due 
to their biochemical similarities to the products of H-2K and D. However, the definition of Class I 
antigens originally included ubiquitous tissue distribution, which along with serologic and functional 
properties clearly distinguishes Qa and TL antigens from Class I. Since it is important to the nature 
of this study to both compare and contrast products of the classical MHC subregions with those of 
the Qa subregion, we have chosen in this report to use the traditional definitions and refer to the H- 
K,D,L, and R antigens as Class I and to the products of Qa and TL loci as Class I-like. 
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above, the first of these is dissimilar tissue distributions. Equally striking is the 
fact that while H-2 antigens display extraordinary structural polymorphism (16- 
18), Qa antigens exhibit extremely low polymorphism (12,  19). 
One  of the  first lines of evidence indicating that  H-2K and H-2D  antigens 
were derived from a common primordial gene was the detection of cross-reactive 
or  "public"  H-2  specificities  shared  by  K  and  D  region  antigens  (20).  This 
hypothesis has subsequently been substantiated by both biochemical and molec- 
ular genetic data (reviewed in reference 21).  It might therefore seem reasonable 
to expect that if other Class I-like gene products are expressed on cell surfaces, 
either as differentiation antigens during ontogeny or on subpopulations of adult 
cells, they might be detected by cross-reactions with anti-Class I (MHC) antibod- 
ies. 
In this laboratory a series of -50 monocional antibodies (MAb) reacting with 
a variety of Class I antigens has been produced (22-25).  During the routine use 
of one of these antibodies as a negative control on a cell population to which it 
was not expected to react, reactivity with subpopulations of splenic lymphocytes 
was  observed.  As  shown  in  this  report,  further  study  of this  cross-reaction 
indicated that the antigen detected was determined by gene(s) mapping to the 
right of the H-2D region, and that the antigen was expressed preferentially on a 
subpopulation of peripheral lymphoid cells. Subsequent studies have shown that 
at least one other Class I specific monoclonal antibody also cross-reacts with this 
new antigen. In this report we present data characterizing the expression of this 
antigen at both genetic and cellular levels, and discuss the implications of these 
findings for the evolution of MHC systems. 
Materials and Methods 
Animals.  Adult male and female mice used were either bred in our own colonies or 
purchased  from the Jackson  Laboratory (Bar Harbor,  ME). B6.K3 (L.  Flaherty)  and 
BALB.A11 (D.  H. Sachs) are newly derived  recombinant congenic strains that will be 
described  in  the Results. C3H.KBR  mice are recombinants  derived  from F2 between 
C3H/HeJ and C3H.SW (26). B6-H-2  k mice were provided by Dr. R. H. Schwartz, NIH 
and were bred from stock originally supplied by Dr. E. A. Boyse. 
Reagents.  The anti-MHC monoclonal antibodies used have been previously described 
(23-25, 27, 28). D3.262 is an IgM monoclonal anti-Qa 2 antibody described elsewhere 
(9). Fluorescein-labeled Rabbit F(ab)'2 anti-mouse IgG2a was produced under contract 
NCI-CB-53912-31 and was provided by Dr. H. B. Dickler, NIH. Fluorescein-conjugated 
(FITC) Goat F(ab)'2 was the gift of B.J. Fowlkes and Dr. R. Asofsky, NIH. Biotin-labeled 
anti-I-A  k monoclonal antibody 10-2.16 (27) and biotin-labeled anti-I-A  b monoclonal anti- 
body 25-9-17 (24) were kindly provided by J. Titus, NIH. Biotin-labeled anti-mouse Thy- 
1.2 (Clone 30-H-12) was purchased  (Cat#  1331) from Becton-Dickinson FACS Systems 
(Sunnyvale, CA). Texas-red conjugated avidin (TRA) was prepared as described previously 
(29), and was the gift of  J. Titus, NIH. 
Two monoclonal anti-MHC antibodies were purified by protein A column separation 
and were fluorescein conjugated. These were 20-8-4, an IgG2a, kappa product of a C3H 
anti-C3H.SW  immunization and fusion to SP2/0  Agl4, and 34-1-2, an IgG2a (kappa) 
product of a C3H anti-BDF~ immunization.  For some experiments,  0.2-ml aliquots of a 
1:8 dilution of monoclonal antibody 20-8-4 were absorbed  with 6 ×  108 normal spleen 
cells of various strains for 60 min at 4°C. 
hnmunofluorescence Staining.  Spleen, lymph node, and thymus cells were prepared by 
gentle  teasing of the organs  with forceps followed by passage through nylon mesh to 
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and tibias using a  25-gauge needle followed by resuspension through a 25-gauge needle 
and passage through nylon mesh to remove clumps. Cell suspensions were prepared in 
Hanks' Balanced Salt Solution containing 10% fetal calf serum, and all further procedures 
were performed using Hanks' Balanced Salt Solution without phenol red containing 0.1% 
bovine serum albumin and 0.1% sodium azide. 
For indirect one-color staining,  1 x  106 cells were incubated at 4°C for 45 min with 
unconjugated antibody, washed twice by centrifugation, incubated at 4°C for 45 min with 
a  fluorescein-conjugated anti-mouse immunoglobulin reagent, washed twice again, and 
finally resuspended  and  analyzed for fluorescence.  For two-color immunofluorescence 
staining,  1 x  106 cells were incubated at  4°C  for 45  min  with  fluorescein-conjugated 
antibody, washed twice,  incubated at 4°C  for 45  rain with biotin-conjugated antibody, 
washed twice,  and incubated at 4°C  for 20  rain  with  Texas-red avidin.  Following this 
incubation, cells were washed twice, resuspended, and analyzed for fluorescence. Controls 
were performed to show that the resulting fluorescence using this staining method was 
identical by FMF analysis with cells were reacted with either set of reagents in separate 
samples or with both sets of reagents in a  single sample. These controls demonstrated 
that there were no competitions or cross-reactions between the reagents used for green 
(fluorescein) fluorescence and those for red (Texas-red) fluorescence. 
For  inhibition  experiments,  1  x  106  cells  were  incubated  at  4°C  for 60  rain  with 
antibody being tested for blocking activity. After 60 rain, fluorescein-conjugated antibody 
was added  in  limiting amounts and  the  incubation  was continued at 4°C  for 20  rain. 
Following this incubation, cells were washed twice, resuspended, and analyzed for fluo- 
rescence. 
Flow Microfluorometry  (FMF) Analysis.  FMF analysis was performed as previously de- 
scribed (30) using a B-D Dual Laser FACS II (Becton-Dickinson FACS Systems, Sunnyvale, 
CA). Fluorescein isothiocyanate (FITC) was excited at 488 nm and Texas-red was excited 
at 568.2 nm. Data on individual cells were collected, stored, displayed, and analzyed using 
a PDP 11/34 computer (Digital Equipment Corporation, Maynard, MA) interfaced to the 
FACS II (31).  Fluorescence data were collected using either linear or logarithmic ampli- 
fication, on 50,000 viable cells as determined by forward light scatter intensity. Logarith- 
mic amplification was provided by a 3-decade logarithmic amplifier constructed from an 
NIH-modified design of R. Hiebert,  LASL (Los Alamos, NM). One-color fluorescence 
data are displayed as cell frequency histograms or immunofluorescence (IF) profiles in 
which logarithmically increasing fluorescence intensity is plotted in 1024 channels on the 
x-axis and cell number is shown on the y-axis.  Two-color immunofluorescence data are 
displayed as contour diagrams in which increasing intensities of green (FITC) fluorescence 
were plotted in  64 channels on the x-axis and increasing intensities of red (Texas-red) 
fluorescence were plotted on the y-axis. Arbitrary levels were selected on the z-axis which 
contained the number of cells at any intersection of x and y values. These levels resulted 
in rings or contours around the peaks of cells correlating red and green fluorescence. 
Data from inhibition experiments were calculated by the formula: 
% Inhibition =  100 -  (Flexp -  Flbkg)/(Flco, -  Flbks), 
where FI --- linear units of fluorescence intensity; exp =  cells stained with FITC-Antibody 
in the presence of a potential inhibitor;  con  =  cells stained with  FITC-Antibody in the 
presence of media; and bkg =  unstained cells. 
Results 
Unexpected Reactivity of MAb 20-8-4.  MAb 20-8-4, an IgG2a product of a C3H 
anti-C3H.SW immunization, was originally characterized by antibody and com- 
plement cytotoxicity on a panel of inbred and recombinant inbred mouse strains. 
On  the  basis of that analysis,  the  MAb  20-8-4  was described  to have anti-H-2 
reactivity to K b,  D b,  K d,  H-2  r, and  H-2  ~ (24).  However, when  20-8-4 was subse- 
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patterns  were  observed  on  both  B10  (Kb,D b,  control  positive)  and  B10.A 
(Kk,D  a,  expected negative) spleen cells.  As shown in  Fig.  1,  the reaction of a 
control  positive  MAb  28-8-6  (anti-Kb, D b)  with  B10  spleen  cells resulted  in  a 
unimodal IF profile (Fig.  1 a) characteristic of spleen cells stained with anti-Class 
I MHC antibodies (32, 33), a pattern of reactivity which suggested that all spleen 
cells bore equivalent amounts of Class I antigens. In contrast, reaction of 20-8-4 
with the same B10 spleen cells unexpectedly gave a bimodal IF profile (Fig.  1 b), 
which  was  of a  similar  intensity  level  to  that  observed  for  28-8-6.  Fig.  1 c 
demonstrates that when 20-8-4 was used to stain B 10.A (used as negative control) 
spleen cells, the resulting IF profile was not only unexpectedly positive but also 
clearly bimodal with both the dull positive and bright positive (relative to the 
fluorescent reagent control) peaks of much lower intensity than those seen with 
B10 spleen cells (Fig.  1, c vs. b). B10.BR and CBH spleen cells did not react with 
20-8-4 since these reactions resulted in IF profiles identical to those from cells 
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FIGURE  1.  IF profiles of spleen cells  reacted with monoclonal anti-MHC antibody (MAb) 
plus FITC anti-IgG2 (  ) or FITC anti-lgG2 only (-- --); (a) BI0 cells with MAb 28-8-8 
(anti-KbDb); (b) B10 cells with MAb 20-8-4; (c) B10.A cells with MAb 20-8-4. SHARROW  ET  AL.  25 
incubated  with  the fluorescent reagent  alone (data not shown), confirming  that 
alloreactivity of 20-8-4 was H-2 linked. 
There  were several possible explanations  for the unexpected  IF profiles seen 
following  20-8-4  staining  on  B10  and  B10.A  spleen  cells.  It  was possible  that 
MAb  20-8-4  culture  supernatant,  although  derived  from  a  cloned  cell  line, 
contained two different antibodies,  one that reacted with H-2 molecules on B 10 
cells and one that reacted  with another  H-2-1inked antigen  expressed  differen- 
tially on spleen cell subpopulations from both B10 and B 10.A. Alternatively,  the 
determinant(s)  detected by 20-8-4 might be physically located such that although 
present  on Class  I  molecules,  (K,  D,  L),  these determinants  were differentially 
accessible to antibody on spleen cell subpopulations,  and a previously undetected 
cross-reaction  on  D a  or  L d was  being  detected  on  B10.A  cells.  Finally,  it  was 
possible that 20-8-4 was indeed a single antibody that reacted with conventional 
Class I MHC antigens but also cross-reacted with a MHC-linked antigen expressed 
differentially on spleen cell subpopulations.  These alternatives were investigated. 
Absorption Analysis  of 20-8-4.  To  eliminate  the  possibility  that  the  20-8-4 
reagent  contained  two antibodies,  the  absorption  experiment  shown  in  Fig.  2 
was performed.  If there existed two antibodies,  both of which reacted with B10 
but only one of which reacted with B10.A, then  B10 but not B10.A cells would 
be expected to absorb all B 10 reactivity from the 20-8-4 reagent.  As can be seen 
in Fig. 2, absorption with B 10.A spleen cells removed all detectable reactivity of 
20-8-4,  as  did  the  absorption  with  B10  spleen  cells.  In  contrast,  the  control 
absorption  with  negative  B10.BR  (Kk,D k)  spleen  cells  did  not  remove  20-8-4 
reactivity on either B10 or B10.A spleen cells, although  the titer of the absorbed 
reagent was slightly lower than the untreated control, presumably due to dilution 
of  the  antibody.  These  results  ruled  out  contamination  of  20-8-4  with  an 
additional  antibody as an explanation  for the unexpected  B10.A reactivity, and 
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FIGURE 2.  Analysis of 20-8-4 reactivity after absorption (See Materials and Methods) with 
nothing (O, O); B10.BR spleen cells (~7, V); B10 spleen cells (A, A); or B10.A spleen cells 
(I-I, II). B 10 (open symbols)  or B 10.A (closed symbols)  spleen cells were incubated with absorbed 
20-8-4 followed by FITC anti-IgG2. 26  CROSS-REACTIVITY  OF ANTI-CLASS I MONOCLONAL ANTIBODIES 
suggested instead that 20-8-4  is a single antibody  that reacts strongly with B10 
cells, as previously described (24),  but also cross-reacts with a previously unde- 
tected determinant on B 10.A spleen cells. 
Mapping Studies and Strain Distribution.  The cross-reaction (CR) of 20-8-4 was 
studied  with a  panel  of inbred  and  H-2  recombinant  inbred  mouse  strains  in 
order  to  map  the  locus  (loci)  which  controlled  expression  of the  previously 
undetected  determinant(s)  on  B10.A  spleen  cells.  Because  20-8-4  also reacted 
with some H-2 antigens, only strains negative for 20-8-4 H-2 reactivity could be 
used. As summarized in Table I, spleen cells from B10.M (H-2¢), B10.P (H-2p), 
and  B10.BR  (H-2  k)  animals  did  not  react  at  all  with  20-8-4.  Because  B10.A 
(H-2  a) and B10.Q (H-2  q) spleen cells were positive (with reactions indistinguish- 
able from that shown in Fig.  1 c), the antigen detected by the 20-8-4 H-2 CR was 
TABLE  I 
Mapping and Strain Distribution of H-2 Cross-Reactive Antigen Detected by Monoclonal Antibody 
20-8-4 
H-2*  Qa*  T 1  a*  H-2 CRI 
Mouse 
subline  K  I  D  Qa2(4)  I  Qa 5  Qa 7  Qa 8  Qa 1  Tla  20-8-4 
BI0  b  b  b  a  a  a  a 
BI0.A  k  k  d  a  b  h  h 
A/J  k  k  d  a  b  b  b 
A.AL  k  k  d  a  b  b 
A.TL  s  k  d  a  b  b  b 
BI0.AQR  q  k  d  a 
BI0.T6R  q  q  d  a 
B10.Q  q  q  q  a  a  b 
BI0.AKM  k  k  q  a 
BI0.BR  k  k  k  b  b  b  b 
C3H/HeJ  k  k  k  b  b  b  b 
C58  k  k  k  b  b  b  b 
AKR/J  k  k  k  b  b  b  b 
BI0.M  f  f  f  b  b  b 
BI0.P  p  p  p  b  b  b 
BALB/cKh  d  d  d  b  b  b  b 
BALB.K  k  k  k 
:[:I:BA  LB.A 11  k  k  d 
B6-T I a ~  b  b  b  a  a  a  a 
B6-H-2  k  k  k  k  b  b 
~B6.K3  k  k  k  a 
BI0.A(2R)  k  k  b  a  a  a 
b  b  ++t 
a  a 
a  a 
c 
b  c 
a  a 
a  a 
b  b 
a  a 
b  b 
d 
a 
b  e  ND** 
ND 
a  a  ND 
b  b  - 
a  a  ++ 
b  b  ++ 
* See references 34 and 26. 
* See references 11, 12, 34-38. 
!  Reactivity of 20-8-4 with non-H-2  antigen(s) as determined  by FMF analysis. High (++) or low (+) reactivity was determined  by 
intensity of 20-8-4 staining. See Figs. I and 5. 
I Qa specificities 2 and 4 have recently been combined to define a single specificity based upon antibody inhibition of H-2 unrestricted 
cytotoxic T  cells (39). Because Qa 3  and Qa 6  have the same strain distribution as Qa 2/4 for all sublines tested  in this study and 
shown  in this Table, they have not been listed separately. 
120-8-4 also has specificity for H-2K  b on B 10) spleen cells. Positive reactivity with H-2CR is presumed because of bimodal I F profile 
(see Fig.  1), and because of positive reactivity of 20-8-4 with BI0.A(2R) cells which carry genes telomeric to H-2D derived from 
BIO. All other strains for which H-2CR typing is shown are do not bear H-2K or D antigens reactive with 20-8-4. 
** ND, not determined. 
tt  New recombinant  inbred mouse subline. See text. SHARROW  ET AL.  27 
controlled by H-2-1inked genes. Spleen cells from two other H-2  a (Kk,D  d) strains, 
A/J  and  A.AL,  as  well  as  B10.AKM  (Kk,D  q)  also  reacted  with  20-8-4  in  an 
identical fashion to B 10.A spleen cells. This suggested that the reaction mapped 
in or to the right of the H-2D subregion.  As can be seen in Table I, the strain 
distribution correlated with that of the Qa 2a(Qa 4a),  Qa 3 and Qa 6 alleles (see 
footnote  II, Table I), but not with the distribution of Qa  1,  Tla, or Qa  5,  7,  8 
alleles. 
In  order to  further map  this  CR  antigen,  two new  recombinants  were em- 
ployed. The first of these was the BALB.A 11, a  new H-2" recombinant derived 
from a backcross of (BALB.K ×  BALB/cKh)Fl to BALB/cKh. The BALB/cKh 
subline, as described previously (35), is Qa 2 b (negative) and might therefore be 
useful for correlation of the CR  with  Qa  2.  However, since  BALB/cKh is  K d 
positive, it could not be tested directly due to the reactivity of 20-8-4 with K d. 
Thus the BALB.A11,  which has Kk,I  k from BALB.K and  D d and genes to the 
right of D  from BALB/cKh (Sachs et al.,  unpublished data), permitted testing 
of H-2D and linked genes from a  Qa 2-negative subline.  As can be seen in Fig. 
3 a, spleen cells from the BALB.A 11 expressed K k and D d. These same cells were 
also positive with anti-I-A k (10-2.16, [27]) and negative with anti-I-A  d (MKD-6, 
[28]) (data not shown),  demonstrating that the BALB.A11  is indeed Kk,D  d.  As 
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FIGURE 3.  IF profiles of spleen cells incubated with MAb followed by FITC anti-lgG2. (a) 
BALB.A  11 with 11-4.1, anti-K  k  (  ), 34-2-12, anti-D  a (-- --) or no MAb (---); (b) BALB.  A 11 
with 20-8-4 (  ) or no MAb (-- --); (c) A/J cells with 20-8-4 (  ) or no MAb (-- --); (d) 
B6.K3 cells with 15-5-5, anti-D  k (  ), 34-2-12, anti-D  a (---) or no MAb (-- --); (e) B6.K3 
cells with 20-8-4 (  ) or no MAb (-- --), BI0.BR cells with 20-8-4 (----); (f) B10.A(2R) cells 
with 20-8-4 (  ) or no MAb (----). 28  CROSS-REACTIVITY  OF ANTI-CLASS I  MONOCLONAL ANTIBODIES 
seen in Fig. 3 b, the BALB.A 11 spleen cells did not react at all with 20-8-4, while 
A/J  cells did  react  to  give  the  characteristic  bimodal  IF  profile.  The  lack of 
reactivity of 20-8-4  with  BALB.A11  therefore  demonstrated  that  20-8-4  does 
not react with D d and that the antigen detected by the 20-8-4 CR is not expressed 
when  the  H-2D-linked  genes are  derived  from  a  BALB subline  that  is  Qa  2 
negative. 
To confirm that  expression of the  20-8-4 CR antigen  was indeed controlled 
by loci to the  right  of H-2D, another  newly derived recombinant,  the  B6.K3, 
was used. The B6.K3 is a recombinant between B6-H-2  k (H-2  k from AKR) and 
B6-Tla  a, itself a recombinant in the Tla region between B6 and A/J. The B6.K3 
expresses the H-2 phenotype of B6-H-2  k (Kk,D  k) and the Qa,Tla phenotype of 
the B-6-TIa  ~ (Qa 2,3,4,5 positive, Tla") (Flaherty et al., unpublished results). The 
results of analysis of spleen cells from the B6.K3 are shown in Fig. 3, c-f. As can 
be seen in Fig.  3d, B6.K3 spleen cells were indeed D k positive and D b negative. 
The same cells were also positive with anti-K k (11-4.1, [27]), negative with anti- 
Kb,D  b (28-8-6,  [28]) and positive with an anti-Qa  2  MAb D3.262  (9) (data not 
shown), confirming  that  B6.K3  is  Kk,D  k and  Qa  2  positive. When  B6.K3 cells 
were stained  with  20-8-4,  the  IF profile shown  in  Fig.  3e was obtained.  Most 
(>90%) spleen cells were positive when compared with control B 10.BR cells and 
the  B6.K3  IF  profile  showed  the  two  distinct  peaks  of fluorescence  intensity 
characteristic  of the new CR antigen.  These results demonstrated that  the new 
antigen is determined by genes to the right of H-2D. 
The  overall  intensity  of staining  of 20-8-4  on  the  B6.K3  cells (Fig.  3e) was 
significantly higher than  that seen when 20-8-4 reacted with A/J cells (Fig.  3 c). 
Fig.  3f shows the  IF profile of 20-8-4  with  B10.A (2R) (Kk,D  b) spleen cells.  It 
was expected that this IF profile would resemble that of B10 cells (Fig.  1 b), since 
20-8-4 was thought to contain  reactivity to D b. However, as the data in Fig.  3f 
demonstrate,  the  reactivity of 20-8-4  on  a  D b  positive strain,  B10.A(2R),  was 
similar to that on B6.K3 cells. This pattern of reactivity of 20-8-4 with B 10.A(2R) 
cells suggested  that  20-8-4  did  not react  with  D b on  these  cells, as previously 
presumed, but rather with the CR antigen. It is significant in this regard that the 
reactivity of 20-8-4 with  B10.A(2R) spleen as measured by cytotoxicity, previ- 
ously thought to define D b reactivity, was of lower magnitude than seen with all 
other positive strains (24). 
The  mapping  studies and  strain  distribution  analysis summarized  in  Table  I 
therefore showed that the 20-8-4 MAb not only reacted with H-2 Class I antigens 
(Kb,K  ~, DS,r) as previously demonstrated, but also cross-reacted with an antigen 
not controlled by genes within the H-2 region, but rather by linked genes outside 
of H-2.  Furthermore,  these studies showed that  the expression  of this antigen 
was correlated with expression of Qa 2. 
Inhibition  of 20-8-4  Reactivity.  In  order  to analyze  further  the  determinants 
detected by the 20-8-4 CR, a variety of antibodies were analyzed for their ability 
to block 20-8-4 FITC reactivity. The antibodies tested were either anti-Class  I 
MHC antibodies or antibodies with no specificity for H-2 antigens,  but reactive 
to Qa region  antigens.  The  results of these studies are shown in  Table  II.  As 
shown in Expt.  1 of this table, one of thirteen  anti-Class  I  MHC MAbs tested, 
34-1-2, was able to block completely the reaction of 20-8-4-FITC with  B10.A SHARROW  ET  AL. 
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Blocking reagent  Test anti-  % Inhibi- 
Expt.  Target* cells 
Antibody  Specificity  body  tion* 
Block  s 
B10.A  28-8-6  Kb,D b  20-8-41  14.7 
28-11-5  Db,Dd,q,p  31.5 
28-13-3  Kb,f  16.8 
27-11-13  Db,Dd,q  21.0 
28-14-8  Ld,Db,q  12.6 
34-1-2  Kd,Dd,Kb,s,r,q,p  103.0 
34-2-12  D d  29.4 
34-4-21  D d  23.1 
34-5-8  D d  -21.0 
15-5-5  D k, Kd,f  14.7 
23-10-1  Ld,q  14.7 
30-5-7  Ld,Dq,Lq,L b  10.5 
3 I-3-4  K d  -6.2 
B10.A(2R)  20-8-4  Kb,Kd,r,s  20-8-4  !  98.9 
34-1-2  Kd,Dd,Kb,r,s,q,p  96.4 
11-4.1  K k  -12.1 
D3.262  Qa 2  18.1 
K1 anti-B6  Qa 2, Qa 4, ?  99.4 
B10.A  20-8-4  94.8 
34-1-2  90.4 
11-4.1  -44.0 
D3.262  26.4 
K1 anti-B6  97.5 
BI0.A(2R)  20-8-4  34-1-2 !  96.8 
34-1-2  96.8 
11-4.1  -31.0 
D3.262  -1.0 
K1 anti-B6  98.7 
3  BI0.A(2R)  20-8-4  D3.262  ~  1.4 
34-1-2  24.8 
11-4.1  -11.7 
* Spleen cells. 
See Materials and Methods. 
0 Positive (+) blocking defined as greater than or equal to 35% inhibition. 
! Fluorescein-conjugated antibody. 
D3.262  (IgM)  followed  by  FITC-Goat  F(ab'),  anti-mouse  IgM.  Blocking  reagents  were  IgG2 
antibodies which in control samples did not react with fluorescent reagent. 
spleen cells. 34-1-2 was derived from a different immunization  and fusion than 
was 20-8-4 (24, 25) and has a different pattern of Class I reactivity (ie specificity) 
than does 20-8-4.  Other anti-Class !  MHC Abs gave minimal  blocking ranging 
from 0 to 30% inhibition. This low level of blocking was found to be nonspecific 
since  four  of  these  antibodies  (28-8-6,  28-14-8,  34-2-12,  and  34-5-8)  were 
unreactive  with  B6.K3  or B10.A(2R) cells by direct  testing  (data  not shown). 
The data in Table II, Expt.  2, demonstrated that 34-1-2 was able to block 20-8- 30  CROSS-REACTIVITY  OF  ANTI-CLASS  I  MONOCLONAL  ANTIBODIES 
4-FITC reactivity on B10.A(2R) as well as on  B10.A spleen cells and that  this 
blocking  was  comparable  to  that  found  with  unlabeled  20-8-4  itself.  Fig.  4a 
shows the IF profiles for 20-8-4-FITC staining of B10.A(2R) spleen cells follow- 
ing pretreatment  with either  34-1-2 or media.  34-1-2 pretreatment can be seen 
to have reduced the  20-8-4-FITC  reaction  to a  level of fluorescence intensity 
close to that of unstained cells. 
The data shown in Table II, Expt.  2, also demonstrate that the anti-Qa  MAb 
D3.262  did  not  block  20-8-4-FITC  reactivity  on  either  B10.A  or  B10.A(2R) 
spleen cells. In contrast, serum from a B6.K1 anti-B6 immunization,  with known 
reactivity to  Qa  2/4  and  Qa  5  and  with  potential  reactivity to other antigens 
controlled  by the  Qa  and  Tla  subregions,  completely  inhibited  20-8-4-FITC 
reactivity on both B10.A and B10.A(2R) cells. Fig. 4b shows that B6.K1 anti-B6 
pretreatment  reduced  the  20-8-4-FITC  reaction  on  B10.A(2R)  cells to  back- 
ground, while either D3.262 or 11-4.1 pretreatment did not. The same antibod- 
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FIGURE  4.  IF profiles of BI0.A(2R) spleen cells; (a) preincubated with media (  ) or 34-1- 
2  (----)  followed  by  20-8-4  FITC;  C,  unstained  cells;  (b)  cells preincubated  with  11-4.1 
(  ), D3.262  (  .... ) or B6.K1 anti-B6 serum (----). SHARROW  ET  AL.  31 
ies were also analyzed for their ability to block 34-1-2 CR reactivity on B10.A(2R) 
spleen cells.  The staining in  this case was identical to  that of 20-8-4  staining, 
showing a  bimodal profile. As the data in  Table II,  Expt.  2,  indicate,  34-1-2- 
FITC reactivity was inhibited by 34-1-2,  20-8-4, and B6.K1  anti-B6 serum, but 
not by 11-4.1  (anti-K  k, reference 27) or D3.262  (anti-Qa 2). This was the same 
result obtained with these reagents when they were used to block 20-8-4-FITC. 
In addition, the data shown in Table II, Expt.  3, demonstrate that 20-8-4 and 
34-1-2 did not block the reactivity of D3.262 with B10.A(2R) spleen cells. 
In summary, the inhibition experiments showed that two anti-Class I  MHC 
MAbs, 20-8-4 and 34-1-2, also detect identical or spatially related determinants 
on an antigen(s) determined by genes that map to the right of the H-2 region. 
Antibodies present in an antiserum against products of this region also detected 
this determinant or spatially related determinants, while a monoclonal anti-Qa 2 
antibody, D3.262 did not. 
Tissue Distribution of the CR Antigen Detected by 20-8-4.  The expression of the 
antigen detected by the 20-8-4 CR was studied on spleen, lymph node, thymus, 
and bone marrow cells using immunofluorescence and FMF analysis. Fig.  5 (a 
and b) illustrates the IF profiles obtained when 20-8-4 was tested on B10.A(2R) 
and B10.A  spleen  cells.  Both  spleen cell sources showed bimodal IF profiles, 
with >80%  of the B10.A(2R)  spleen cells and  50%  of the B10.A  spleen cells 
above background. B 10.A(2R) spleen cells were 6-10 times brighter than B 10.A 
spleen cells in repeated experiments. The dull peak of B10.A spleen cells was 
variable in intensity from animal to animal such that only 40-80% of B10.A cells 
could be routinely detected as clearly positive relative to background. However 
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IF profiles of spleen (a  and b) or thymus (c and  d) cells reacted with  20-8-4 
followed by FITC anti-IgG2 (  ) or FITC anti-IgG2 only (-- --). Cells were from B 10.A(2R) 
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IF  profiles  such  as  that  shown  in  Fig.  5b  suggested  that  indeed  most  B10.A 
spleen cells were positive. 
The IF profiles obtained for 20-8-4 on thymus cells are shown in Fig. 5, c and 
d.  Only  small  subpopulations  of thymocytes  were  positive  above background. 
The positive B 10.A(2R) thymocytes (5.7%) were much brighter than the positive 
B 10.A thymocytes (5.6%).  For both strains,  the positive thymocyte peaks of cells 
were of the same  fluorescence  intensity as the bright  positive spleen  cells from 
the same animal. 
To assess further  the  relative  reactivities  of 20-8-4  and  D3.262  (anti-Qa  2), 
these MAbs were studied with B10.A(2R) and B10.A bone marrow cells (Fig. 6). 
The  IF profile obtained with  20-8-4 on B10.A(2R) bone marrow cells (Fig. 6a) 
showed  three  subpopulations:  negative  cells  (78%  of total),  dull  positive  cells 
(16%),  and  bright  cells (6%).  The  small  bright  subpopulation  was of the  same 
intensity as the bright subpopulation of positive spleen cells and the small positive 
subpopulation  of thymocytes from the same animal (Fig.  6a vs. Fig.  5, a  and c). 
The  B10.A  bone  marrow  IF  profile  with  20-8-4  also  showed  a  small  positive 
subpopulation  (8% of total) that  correlated  in intensity with the bright  subpop- 
ulations in B10.A spleen and thymus (Fig. 6b vs. Fig. 5, b and d). The remainder 
of the  B10.A  bone  marrow  cells  were not  clearly above background  although 
the  IF  profile  shown  in  Fig.  6b  suggested  that  there  might  be  an  additional 
weakly positive subpopulation  similar to that found in B10.A (2R) bone marrow 
cells. 
4 
2 
'-  1 
X 
0 
N-- °:I 
..0 
E 
z 
0 
FIGURE  6. 
B10.A(2R)  Bone  Marrow 
a  4 
2 
20-8-4  1 
0 
B10.A  Bone  Marrow 
c  b 
20-8-4 
c  d 
1  2  3  0  1  2  3 
Log10 Fluorescence Intensity 
IF profiles of BI0.A(2R) (a and c) or BI0.A (b and d) bone marrow cells; a and b 
cells reacted  with 20-8-4 (  ) or 25-9-17 (lgG2a, anti-I-A  b) control (C) antibody (----) 
followed by FITC anti-lgG2; c and d cells reacted with D3.262 (  ) or 25-5-16 (IgM, anti-l- 
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The reactivity of D3.262  with the same bone marrow cells (Fig.  6,  c and d) 
was very different from that found with 20-8-4.  One striking observation was 
that the overall intensity of staining did not differ between the two strains, such 
that  B10.A  bone  marrow  cells  were  of  the  same  intensity  as  those  from 
B 10.A(2R). When spleen cells from the same animals were analyzed with D3.262, 
B10.A(2R) Ig- cells were only 1.5 times brighter than B10.A Ig- cells (data not 
shown). In addition, the shape of the IF profiles shown in Fig. 6 suggested that 
most bone marrow cells from both strains were positive with D3.262, although 
only 40%  (B10.A(2R)) and 36% (B10.A) were clearly positive after subtraction 
of background. 
The  tissue  distribution  analysis of the  antigen  detected by  the  20-8~  CR 
demonstrated that this antigen was expressed on most, if not all spleen cells, but 
only on  small  subpopulations  of thymus and  bone  marrow  cells.  Spleen  and 
lymph node cells (see below) gave similar IF profiles and each clearly contained 
two subpopulations that differed significantly in their levels of expression of this 
antigen. Finally, the expresion of the CR antigen was different on bone marrow 
cells than that of Qa 2, as defined by the D3.262 monoclonal antibody. 
Two-Color Immunofluorescence Analysis of the 20-8-4 CR.  Two-color immunoflu- 
orescence analysis  was  performed to  determine whether or  not  the  bimodal 
distribution of staining by 20-8-4 correlated with B and T  cell subpopulations. 
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FIGURE  7.  Two-color immunofluorescence analysis contour plots (see Materials and Meth- 
ods).  B10.A(2R) (a-c) or B10.A (d-f) lymph node cells were stained for green fluorescence 
with 20-8-4  FITC (a,  b, d, e) and for red fluorescence with biotin-anti-Thyl.2 (a and d) or 
biotin anti-I-A  k,  10-2.16 (b and e) followed by TRA. c andfcells stained only with TRA. 34  CROSS-REACTIVITY  OF  ANTI-CLASS  I  MONOCLONAL  ANTIBODIES 
Examples of contour analyses of the correlation  between 20-8-4  CR and either 
Thy-l.2 or I-A expression are shown in Fig. 7. Analysis of B10.A(2R) and B10.A 
lymph node cells stained with 20-8-4-FITC (green fluorescence) and biotinylated- 
anti-Thy-l.2  plus TRA (red fluorescence) (Fig.  7, a and d) showed that in both 
strains  all  20-8-4  bright  cells  were  Thy-l.2  positive.  Reciprocally,  all  Thy-l.2- 
positive  B10.A(2R)  cells  and  85%  of Thy-l.2-positive  B10.A  cells  were  also 
bright for 20-8-4 CR. Low numbers of Thy-l.2-positive,  20-8-4 dull, cells were 
consistently seen in both lymph node and spleen cells from  B 10.A animals,  but 
were never found in B10.A(2R) spleen or lymph node cells. Fig.  7, b and c show 
a  similar  analysis  between  staining  for  20-8-4  CR and  anti-I-A k.  In  agreement 
with the Thy-l.2  correlation,  the majority of 20-8-4 dull cells from both strains 
were I-A positive.  Fig.  7, c andfshow  the control  contour analyses of the same 
cells reacted with only media (green  fluorescence) and TRA (red fluorescence). 
Results similar to those shown in Fig. 7 were obtained with spleen cells from the 
same animals (data not shown). These data thus demonstrate that the H-2-1inked 
antigen  detected  by  20-8-4  is  preferentially  expressed  on  peripheral  T  cells, 
although  non-T cells express low amounts of the antigen. 
A  similar  two-color immunofluorescence  analysis was performed  to assess the 
reactivity of 20-8-4 via its anti-MHC  specificity (Fig.  8). In this experiment,  20- 
8-4  subpopulation  reactivity  on  B10.A(2R)  cells  (which  express  only  the  CR 
antigen  and  not  H-2K  or  D  antigens  reactive  with  20-8-4)  was  compared  to 
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subpopulation  reactivity  on  C3H.KBR  (see  Materials  and  Methods)  cells. 
C3H.KBR expresses H-2K b which is reactive with 20-8-4, but not the CR antigen 
because the  H-2D  and  Qa/Tla  regions of this animal are  derived from C3H 
which  is  negative  for  the  CR  antigen  (see  Table  I).  B10.A(2R)  spleen  cells 
contained Thy-l.2-positive,  20-8-4 bright cells (Fig. 8a), and I-A  k positive, 20- 
8-4 dull cells (Fig. 8 b), a result compatible with data shown in Fig. 7. In contrast, 
when  subpopulation  analysis  of  C3H.KBR  (Kb,Ib,Dk,Qa  2 b)  spleen  cells  was 
performed, the 20-8-4 antibody did not discriminate between T  cells and B cells 
(Fig. 8, c and d). Thus, Thy-1.2 positive cells were of the same green fluorescence 
(20-8-4) intensity as Thy-l.2-negative cells (Fig. 8c). Unlike B10.A(2R) cells, I- 
Ab-positive C3H.KBR cells were no less intense with 20-8-4-FITC than were I- 
Ab-negative cells (compare  Fig.  8,  b vs.  d).  B10.BR  spleen cells reacted  with 
Thy-l.2 (Fig. 8e) and anti-I-A k (Fig. 8f), but were, as expected, negative with 
20-8-4-FITC.  Therefore, two-color immunofluorescence analysis demonstrated 
that the single MAb, 20-8-4, reacted with Class I antigens equally on T  cells and 
B  cells, but also  reacted  with a  different,  H-2-1inked,  antigen  predominantly 
expressed on T  cells. 
Discussion 
The present  study demonstrates serological cross-reactivity between  Class  I 
MHC  molecules  (H-2)  and  an  H-2-1inked  differentiation  antigen  expressed 
predominantly on T  cells and determined by genes that map to the right of H- 
2D. Two anti-Class  I  MHC-specific monoclonal antibodies (20-8-4 and 34-1-2) 
have been found that cross-react with this H-2 CR antigen. The cross-reactive 
determinant(s) is expressed on an antigen that can be tentatively classified as a 
Qa  antigen  by  genetic  mapping as  well  as  strain  and  tissue  distribution.  In 
addition, an antiserum specific for products of the Qa/Tla region blocks reactivity 
of the anti-Class  I  MHC  antibodies with the  H-2  cross-reactive (CR) antigen. 
Although the reaction of anti-Class  I  MHC MAbs with this H-2 CR antigen is 
inhibited by B6.K1 anti-B6 serum, the determinants being detected by the serum 
and the MAbs must be different. Both MAbs react strongly with K b, while the 
B6.K1  animal,  which  itself expresses  K b,  would  not be  expected  to  produce 
detectable antibodies reactive with this antigen. Consistent with this expectation, 
reactivity of the MAbs to K b itself, rather than the H-2CR antigen, is not inhibited 
by B6.K1  anti-B6  serum (data not shown). Therefore,  it seems likely that the 
B6.K1 anti-B6 serum and the anti-H-2 MAbs detect distinct, but spatially related 
determinants on the same epitope of the H-2 CR antigen. One prediction of this 
analysis is that cross-reactive antibodies such as the ones described in the present 
study might be readily detected only in immunizations in which the responder 
animal and the immunizing cells differ at H-2. 
The Tla region of the mouse genome located telomeric to H-2D is known to 
contain at least two subregions on the basis of recombinant events between Qa 
2 and TL (12).  Both TL antigens and the Qa  1 antigen are controlled by the 
TL  subregion  and  consist  of specificities  distinct  from  the  H-2  CR  antigen 
reported in the present study on the basis of strain distribution (see Table I). Qa 
6 is thought to be controlled by loci within the TL subregion (37), while Qa 2- 
5,7,8 are controlled by the Qa subregion (12, 38). While differences in thymus, 36  CROSS-REACTIVITY  OF  ANTI-CLASS  I  MONOCLONAL  ANTIBODIES 
bone marrow, and B cell expression have been reported for these antigens, they 
are all expressed predominantly on peripheral T  cells (12, 37, 38) as is the CR 
antigen described in the present study. Qa 2-8 antigens also share similar, but 
not identical, strain distributions distinguished by the fact that only strains that 
are Qa 2 positive express any of the remaining Qa 3-8 specificities (12, 37, 38). 
The CR antigen reported here appears to be distinct from Qa 5,7,8 on the basis 
of strain  distribution  (see  Table  I).  While  the  expression  of the  CR  antigen 
correlates with that of Qa  2,3,6  by strain distribution, it appears to be distinct 
because (a) the reactivity of 20-8-4 with the CR antigen is not inhibited by the 
D3.262 (anti-Qa 2) MAb; (b) the expression of this CR antigen on bone marrow 
cells, as shown in this study, is markedly different from that of Qa 2 as detected 
by D3.262; (c) two other recently described anti-Qa 2 MAbs have been reported 
to identify B cell subpopulations (10,  1 I), while the 20-8-4 reaction with the CR 
antigen does not; (d) Unlike Qa  3 and Qa 6  which have not been detected on 
thymocytes (12,  38),  the CR antigen  has been  found on  ~5%  of thymocytes. 
Therefore, if one considers previous reports on Tla region antigens, it appears 
that  the anti-Class  I  MAb cross-reactivity  described here  detects a  previously 
undefined Qa antigen or specificity. However,  there is sufficient ambiguity in 
the definition of previously defined Qa antigens to make overlap possible, and 
we have therefore not assigned a  definite Qa specificity for the CR antigen to 
date. The data presented here illustrate that analysis of this type of antigen with 
MAbs  and  flow  microfluoremetry  permits  highly  reproducible  and  sensitive 
quantitation on different cellular subpopulations and mouse strains, thus provid- 
ing less ambiguous definition of the antigen than has previously been described. 
Recent molecular analyses of the mouse genome (reviewed in detail, reference 
21)  have  demonstrated the existence of numerous DNA  sequences that  cross 
hybridize with H-2  Class  I  DNA  probes,  suggesting that these sequences may 
constitute a  large gene family derived from a common ancestral gene (3, 4). It 
has  been  suggested that  genes  linked to  H-2,  even  if unexpressed in  normal 
tissues,  may  somehow  be  involved  in  the  generation  of H-2  polymorphism, 
possibly by a  gene conversion mechanism (40-42).  In addition, some or all of 
these genes may be expressed in a different fashion from classical Class I products. 
Rather than being expressed ubiquitously, they could, for example, be expressed 
only  on  specific  tissues  or  at  certain  times  during  ontogeny.  As  such,  these 
antigens could serve differentiation or tissue-specific functions. 
By definition, the new Qa determinant(s) described in this study shares sero- 
logical  cross-reactivity  with  classical  H-2  Class  I  MHC  antigens.  Serologicaily 
cross-reactive  anti-Qa  1 alloantisera  detecting  H-2  Class  I  antigens  (K  f)  have 
previously been reported (43, 44), although anti-Qa cross-reactivity in anti-H-2 
K f alloantisera could not be detected (43). In addition, reactivity to Qa 2 by anti- 
K b  alloantisera  has  been  reported  (45).  However,  such  sera  are  composed of 
complex mixtures of antibodies, and the basis of the cross-reactions is therefore 
more difficult to interpret. In the present study, the same MAbs shown to cross- 
react with a Qa-like antigen also react with known H-2 products. In fact, these 
two MAbs are extremely cross-reactive among H-2 Class I antigens (24, 25) and 
have recently been reported to detect two H-2K products in the H-2 d haplotype 
(46). Serologic cross-reactivity between the products of H-2 Class I MHC genes SHARROW  ET  AL.  37 
and those of genes telomeric to  H-2D  suggests that  these genes may share a 
common origin and structure. This antigen therefore fits precisely the charac- 
teristics predicted for a  product of one of the many Class  I-like genes defined 
by DNA hybridization studies but previously unrecognized as an expressed gene. 
Confirmation of this prediction must await identification of the gene responsible 
for the CR specificity, and studies using L  cell transformants bearing Class-I- 
like genes are in progress for this purpose. 
A parallel of possible significance can be drawn between the lymphoid expres- 
sion of this CR antigen and of Ia antigens. Both are determined by H-2-1inked 
genes and  both  show a  more  limited tissue  distribution  than  do  Class  I  H-2 
antigens.  By two-color immunofluorescence analysis,  there  is  an  almost  com- 
pletely inverse correlation between I-A antigen and H-2 CR antigen expression 
on spleen and lymph node cells. This inverse relationship may be fortuitous, or 
it  may provide a  clue to  the possible  function of the CR  antigens in  cellular 
immune interactions. The availability of MAbs which react with both Class I and 
Class  I-like gene products also has possible practical implications. Because each 
of these antibodies reacts with both  H-2 and non-H-2  antigens derived from 
genes  with  striking  homologies,  a  single  probe  can  now  be  used  to  analyze 
similarities in the products of these genes. These antibodies may also be useful 
in  analysis  of  factors  which  control  the  differences  in  tissue  and  temporal 
expression of H-2 vs. H-2-1inked homologous genes. 
Suillmary 
Analysis of anti-Class I major histocompatibility complex (MHC) monoclonal 
antibodies by immunofluorescence and flow microfluorometry demonstrated an 
unexpected cross-reactivity. Two of fifteen antibodies examined (20-8-4,  anti- 
Kb,Kd,r,s  and 34-i-2,  antiKd,Dd,Kb, r,s,q,p)  were observed to detect an antigen 
determined by gene(s) mapping to the right of H-2D. Two-color immunofluo- 
rescence analysis demonstrated that  this antigen, unlike classical  H-2K and  D 
antigens, was expressed in high amounts on peripheral T  cells, but only weakly 
on  Ia-positive cells and on  small subpopulations  of thymus and bone  marrow 
cells.  Mapping,  absorption,  blocking, and tissue distribution  studies suggested 
that the cross-reactive antigen is Qa-like, but distinct from previously described 
Qa antigens. Thus, these data demonstrate serological cross-reactivity between a 
Class  I MHC antigen and a differentiation antigen determined by genes linked 
to H-2.  It seems likely that the gene responsible for this new antigen is one of 
the numerous Class  I-like sequences detected by DNA hybridization analyses, 
but previously undefined in terms of tissue expression. These data suggest that 
many of these DNA sequences may be expressed in specific tissues and that cross- 
reactions  of anti-Class  I  MAbs  may  provide  useful  probes  for  studying  the 
products of such homologous genes. 
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